FDA 510(k)

Apollo ESG NXT 系统，Apollo REVISE NXT 系统

K号: K232544 · 2023-09-18

决定日期2023-09-18

产品代码QTD

咨询委员会GU 请注意，由于您只提供了“GU”这个词，我无法提供完整的翻译。如果您能提供完整的句子或段落，我将能够为您提供准确的翻译。

决定实质等同

器械摘要

Apollo ESG NXT System, Apollo REVISE NXT System is the device name listed in this FDA 510(k) record. The listed applicant is Apollo Endosurgery, Inc.. It received FDA 510(k) clearance on 2023-09-18 under 510(k) number K232544. The device is classified under product code QTD. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the Apollo ESG NXT System, Apollo REVISE NXT System?

Apollo ESG NXT System, Apollo REVISE NXT System is a medical device that received FDA 510(k) clearance on 2023-09-18. The listed applicant is Apollo Endosurgery, Inc.. The 510(k) number is K232544.

When did Apollo ESG NXT System, Apollo REVISE NXT System receive FDA 510(k) clearance?

Apollo ESG NXT System, Apollo REVISE NXT System received FDA 510(k) clearance on 2023-09-18, under 510(k) number K232544.

Who is the listed applicant for Apollo ESG NXT System, Apollo REVISE NXT System?

The FDA 510(k) record lists Apollo Endosurgery, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Apollo ESG NXT System, Apollo REVISE NXT System?

The FDA product code for Apollo ESG NXT System, Apollo REVISE NXT System is QTD.

列明Apollo Endosurgery, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K231553OverStitch NXT 内窥镜缝合系统 K210266OverStitch Sx 内窥镜缝合系统 K201808X-Tack 内窥镜 HeliX 稳定系统 K171886OverStitch SX 内窥镜缝合系统 (ESS)

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。

器械摘要

常见问题

相关临床试验

列明Apollo Endosurgery, Inc.为申报人的其他记录

官方来源